Treatment with AKG or CaAKG ameliorates long‐term potentiation (LTP) at hippocampal CA1 synapses in APP/PS1 mice, with a more profound effect in female AD mice than in males. The gene discussed is PSEN1; the disease is Alzheimer disease.